✦ LIBER ✦

PP56 Prostate-specific antigen doubling time in metastatic castration-resistant prostate cancer: a clinically useful prognostic factor

✍ Scribed by G. Colloca; D. Guarneri; G. Addamo; A. Venturino; Z. Coccorullo; R. Ratti; E. Campora

Book ID: 119600891
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 48 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(09)72151-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prostate-specific antigen doubling time

Prostate-specific antigen doubling time and survival in patients with advanced metastatic prostate cancer

✍ Robert D Loberg; Jeffery R Fielhauer; Brian A Pienta; Scott Dresden; Patty Chris 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Prostate-specific antigen kinetics as a

Prostate-specific antigen kinetics as a surrogate endpoint in clinical trials of metastatic castration-resistant prostate cancer: A review

✍ G. Colloca 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 182 KB

A phase II trial of personalized peptide

A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time

✍ Noguchi, Masanori; Moriya, Fukuko; Suekane, Shigetaka; Ohnishi, Rei; Matsueda, S 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 600 KB

Glasgow Prognostic Score As a Prognostic

Glasgow Prognostic Score As a Prognostic Factor in Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel-Based Chemotherapy

✍ Linton, Anthony; Pond, Greg; Clarke, Stephen; Vardy, Janette; Galsky, Matthew; S 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 436 KB

Denosumab and Bone Metastasis-Free Survi

Denosumab and Bone Metastasis-Free Survival in Men With Nonmetastatic Castration-Resistant Prostate Cancer: Exploratory Analyses by Baseline Prostate-Specific Antigen Doubling Time

✍ Smith, M. R.; Saad, F.; Oudard, S.; Shore, N.; Fizazi, K.; Sieber, P.; Tombal, B 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 250 KB

S207 Comparing prostate specific antigen

S207 Comparing prostate specific antigen doubling time and prostate specific antigen velocity as predictors of prognosis and survival in hormone-resistant prostate cancer patients

✍ Sabur, V.; Demirtas, A.; Baydilli, N.; Akinsal, E.C.; Demirci, D.; Ekmekcioglu, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 85 KB